These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 22089535)
1. Aliskiren reduced renal fibrosis in mice with chronic ischemic kidney injury--beyond the direct renin inhibition. Sun CY; Cherng WJ; Jian HZ; Hsu HH; Wu IW; Hsu HJ; Wu MS Hypertens Res; 2012 Mar; 35(3):304-11. PubMed ID: 22089535 [TBL] [Abstract][Full Text] [Related]
2. Aliskiren ameliorates renal inflammation and fibrosis induced by unilateral ureteral obstruction in mice. Choi DE; Jeong JY; Lim BJ; Chang YK; Na KR; Shin YT; Lee KW J Urol; 2011 Aug; 186(2):694-701. PubMed ID: 21683401 [TBL] [Abstract][Full Text] [Related]
3. AT1 antagonism and renin inhibition in mice: pivotal role of targeting angiotensin II in chronic kidney disease. Fraune C; Lange S; Krebs C; Hölzel A; Baucke J; Divac N; Schwedhelm E; Streichert T; Velden J; Garrelds IM; Danser AH; Frenay AR; van Goor H; Jankowski V; Stahl R; Nguyen G; Wenzel UO Am J Physiol Renal Physiol; 2012 Oct; 303(7):F1037-48. PubMed ID: 22791343 [TBL] [Abstract][Full Text] [Related]
4. Long-term antihypertensive effects of aliskiren, a direct renin inhibitor, in chronic hemodialysis patients. Ishimitsu T; Ohta S; Ohno E; Takahashi T; Numabe A; Okamura A; Ohba S; Hashimoto A; Matsuoka H Ther Apher Dial; 2013 Oct; 17(5):524-31. PubMed ID: 24107281 [TBL] [Abstract][Full Text] [Related]
5. Renal protective effects of aliskiren beyond its antihypertensive property in a mouse model of progressive fibrosis. Gross O; Girgert R; Rubel D; Temme J; Theissen S; Müller GA Am J Hypertens; 2011 Mar; 24(3):355-61. PubMed ID: 21127470 [TBL] [Abstract][Full Text] [Related]
6. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?]. Horký K Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167 [TBL] [Abstract][Full Text] [Related]
7. Effects of aliskiren on blood pressure and the predictive biomarkers for cardiovascular disease in hemodialysis-dependent chronic kidney disease patients with hypertension. Morishita Y; Hanawa S; Chinda J; Iimura O; Tsunematsu S; Kusano E Hypertens Res; 2011 Mar; 34(3):308-13. PubMed ID: 21124333 [TBL] [Abstract][Full Text] [Related]
8. [Renin inhibition and the kidney]. Ecder T Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():28-31. PubMed ID: 20019474 [TBL] [Abstract][Full Text] [Related]
9. Treatment combining aliskiren with paricalcitol is effective against progressive renal tubulointerstitial fibrosis via dual blockade of intrarenal renin. Chung S; Kim S; Kim M; Koh ES; Shin SJ; Park CW; Chang YS; Kim HS PLoS One; 2017; 12(7):e0181757. PubMed ID: 28753620 [TBL] [Abstract][Full Text] [Related]
10. Aliskiren attenuates chronic carbon tetrachloride-induced liver injury in mice. Lee KC; Chan CC; Yang YY; Hsieh YC; Huang YH; Lin HC Eur J Clin Invest; 2012 Dec; 42(12):1261-71. PubMed ID: 22998019 [TBL] [Abstract][Full Text] [Related]
11. Renin inhibition reverses renal disease in transgenic mice by shifting the balance between profibrotic and antifibrotic agents. Kavvadas P; Weis L; Abed AB; Feldman DL; Dussaule JC; Chatziantoniou C Hypertension; 2013 Apr; 61(4):901-7. PubMed ID: 23438929 [TBL] [Abstract][Full Text] [Related]
12. [Direct renin inhibitor aliskiren in the treatment of cardiovascular and renal diseases]. Horký K Vnitr Lek; 2010 Feb; 56(2):120-6. PubMed ID: 20329582 [TBL] [Abstract][Full Text] [Related]
13. Addition of aliskiren to olmesartan ameliorates tubular injury in chronic kidney disease patients partly by reducing proteinuria. Nakamura T; Sato E; Amaha M; Kawagoe Y; Maeda S; Yamagishi S J Renin Angiotensin Aldosterone Syst; 2012 Mar; 13(1):122-7. PubMed ID: 21946392 [TBL] [Abstract][Full Text] [Related]
14. Concomitant inhibition of renin angiotensin system and Toll-like receptor 2 attenuates renal injury in unilateral ureteral obstructed mice. Chung S; Jeong JY; Chang YK; Choi DE; Na KR; Lim BJ; Lee KW Korean J Intern Med; 2016 Mar; 31(2):323-34. PubMed ID: 26932402 [TBL] [Abstract][Full Text] [Related]
15. [The future of renin inhibition]. Uresin AY; Baran E Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475 [TBL] [Abstract][Full Text] [Related]
16. Aliskiren and perindopril reduce the levels of transforming growth factor-β in patients with non-diabetic kidney disease. Lizakowski S; Tylicki L; Renke M; Rutkowski P; Heleniak Z; Sławińska-Morawska M; Aleksandrowicz-Wrona E; Małgorzewicz S; Rutkowski B Am J Hypertens; 2012 Jun; 25(6):636-9. PubMed ID: 22357413 [TBL] [Abstract][Full Text] [Related]
17. Aliskiren attenuates proteinuria in mice with lupus nephritis by a blood pressure-independent mechanism. Yen TH; Yang HY; Yeh YH; Chu PH; Wen CJ; Fu JF; Wang IK; Liang CC; Chang CT; Chen KH; Tian YC; Hung CC; Lin JL; Yang CW Lupus; 2013 Feb; 22(2):180-9. PubMed ID: 23257405 [TBL] [Abstract][Full Text] [Related]
18. Renin inhibition by aliskiren prevents atherosclerosis progression: comparison with irbesartan, atenolol, and amlodipine. Nussberger J; Aubert JF; Bouzourene K; Pellegrin M; Hayoz D; Mazzolai L Hypertension; 2008 May; 51(5):1306-11. PubMed ID: 18391092 [TBL] [Abstract][Full Text] [Related]
19. The direct renin inhibitor aliskiren localizes and persists in rat kidneys. Feldman DL; Jin L; Xuan H; Persohn E; Zhou W; Schuetz H; Park JK; Muller DN; Luft FC Am J Physiol Renal Physiol; 2013 Dec; 305(11):F1593-602. PubMed ID: 23926182 [TBL] [Abstract][Full Text] [Related]
20. Aliskiren increases bradykinin and tissue kallikrein mRNA levels in the heart. Campbell DJ; Zhang Y; Kelly DJ; Gilbert RE; McCarthy DJ; Shi W; Smyth GK Clin Exp Pharmacol Physiol; 2011 Sep; 38(9):623-31. PubMed ID: 21736602 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]